GastroIntestinal Bleeding Clinical Trial
Official title:
Analysis of Metabolomics of Blood Degradation/Digestion Using in Vitro Digestion Model to Identify Potential Biomarkers of Gastrointestinal Bleeding
Despite advances in gastrointestinal endoscopy and pharmaceuticals, gastrointestinal bleeding is still a significant emergency disease with a high mortality rate of 1.9-5 per 100 people due to excessive bleeding and shock. There are several indicators using pulse rate, blood pressure, hemoglobin, etc. to select patients who require endoscopic intervention, or hospitalization, but these are inaccurate and with a high false-positive rate and low specificity at 35-40%. Therefore, tests with high diagnostic accuracy for gastrointestinal bleeding patients are required and findings specific biomarkers for gastrointestinal bleeding are of great importance.
Recently, with the development of metabolomics, efforts are being made to improve the diagnosis and treatment of diseases through metabolomics analysis, but there are no studies related to gastrointestinal bleeding. If the degradation/metabolism process of blood that accumulates in the gastrointestinal tract is well studied and understood, there is a possibility of finding specific biomarkers for gastrointestinal bleeding. Thus, this study aims to analysis of metabolomics of blood degradation/digestion using in vitro digestion model to identify potential biomarkers of gastrointestinal bleeding. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05060731 -
Iron Supplementation in Upper Non-variceal Gastrointestinal Bleeding
|
Phase 4 | |
Recruiting |
NCT05949268 -
Video Capsule Endoscopy for Detection of Gastrointestinal Bleeding in the Small Bowel
|
||
Not yet recruiting |
NCT03243240 -
Computed Tomography in Gastrointestinal Bleeding
|
N/A | |
Completed |
NCT02595853 -
Efficacy of a Novel Hemostatic Powder in GI Bleeding
|
||
Completed |
NCT01434108 -
Effects of the Administration of Ornithine Phenylacetate in Patients With Cirrhosis and Upper Gastrointestinal Bleeding
|
Phase 2/Phase 3 | |
Terminated |
NCT01756690 -
Predicting Lung Injury From Transfusion in Patients With Liver Disease
|
N/A | |
Completed |
NCT01424254 -
The Effectiveness of Video-capsule Endoscopy in Gastrointestinal Bleeding of Obscure Origin
|
Phase 3 | |
Completed |
NCT05884931 -
Effectiveness and Safety of Nexpowder as an Endoscopic Hemostatic Treatment
|
N/A | |
Completed |
NCT01335516 -
Follow-up of Glypressin (Terlipressin) Clinical Efficacy in the Treatment of Bleeding Oesophageal Varices
|
N/A | |
Withdrawn |
NCT00401908 -
Factors Contributing To Cardiovascular Morbidity and Mortality in Patients With Gastrointestinal Bleeding
|
N/A | |
Recruiting |
NCT05024864 -
HELicobacter Pylori Screening to Prevent Gastrointestinal Bleeding in MI Patients
|
N/A | |
Completed |
NCT05008640 -
Creation of an E-toileting Log Through Classification of the Physical Properties of Stool and Urine Using TrueLoo™
|
||
Recruiting |
NCT06259292 -
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
|
||
Completed |
NCT03716466 -
Evaluation of Prophylactic Endotracheal Intubation
|
||
Completed |
NCT05362227 -
High-Volume Vs Low-Volume Preparation in Emergency Department
|
N/A | |
Completed |
NCT02405286 -
Prospective Assessment of the Rockall Risk ScoringSystem in Patients With Upper Gastrointestinal Hemorrhage
|
N/A | |
Recruiting |
NCT00562445 -
Adrenal Insufficiency in Critical Emergencies in Digestive Diseases
|
N/A | |
Recruiting |
NCT05290857 -
Anticoagulation After GI Bleeding Pilot Study and Registry
|
N/A | |
Recruiting |
NCT02863250 -
Australian and New Zealand Massive Transfusion Registry
|
||
Completed |
NCT01415869 -
Occult Gastrointestinal Bleeding in Non-pulsatile Left Ventricular Assist Device(VAD)Patients
|